ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.956,17
0,59%
S&P 500
6.037,59
1,06%
Dow Jones
43.325,80
0,00%
Euro vs US Dollar
1,04327
0,10%
Bitcoin
96.532,80
0,89%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Rhythm Pharmaceuticals Inc (RYTM) Börsenkurse

Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Inc (RYTM)

NASDAQ
56,54
0,69
(1,24%)
Geschlossen 27 Dezember 10:00PM
Verzögert um 15 Minuten
56,54
0,00
( 0,00% )
Vor Marktöffnung: 1:00PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
56,54
Gebot
52,13
Fragen
58,00
Volumen
15
0,00 Tagesbereich 0,00
35,17 52-Wochen-Bereich 68,58
Marktkapitalisierung
3,475B
Handelsende
56,54
Handelsbeginn
-
Letzte Trade
1
@
57
Letzter Handelszeitpunkt
12:41:28
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
537.054
Ausgegebene Aktien
61.457.069
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-18,82
Gewinn pro Aktie (EPS)
-3,01
Erlöse
77,43M
Nettogewinn
-184,68M

Über Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanot... Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.rhythmtx.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Rhythm Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RYTM. The last closing price for Rhythm Pharmaceuticals was US$56,54. Over the last year, Rhythm Pharmaceuticals shares have traded in a share price range of US$ 35,17 to US$ 68,58.

Rhythm Pharmaceuticals currently has 61.457.069 shares in issue. The market capitalisation of Rhythm Pharmaceuticals is US$3,47 billion. Rhythm Pharmaceuticals has a price to earnings ratio (PE ratio) of -18.82.

RYTM Neueste Nachrichten

Weitere Nachrichten

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old

BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare...

20 Dezember 2024
GlobeNewswire Inc.

Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to incl

BOSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living...

03 Dezember 2024
GlobeNewswire Inc.

Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide

-- Four Pediatric patients treated in French early-access program achieved meaningful weight reduction at three months on setmelanotide therapy -- -- Rhythm announced plans for a new substudy to...

18 November 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

14 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

14 November 2024
Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

14 November 2024
Edgar (US Regulatory)

Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology

BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living...

14 November 2024
GlobeNewswire Inc.

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare...

13 November 2024
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

12 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

08 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.951.7089404569255.5958.1654.2976486856.13952396CS
4-5.78-9.2747111681662.3262.5553.3954588157.12452487CS
127.5415.3877551024968.5846.853705457.43373876CS
2616.5341.314671332240.0168.5839.4748171453.1520543CS
528.3417.302904564348.268.5835.1754855147.10482626CS
15644.34363.44262295112.268.583.0479537524.55368582CS
26033.84149.07488986822.768.583.0460432823.87464734CS

RYTM - Frequently Asked Questions (FAQ)

What is the current Rhythm Pharmaceuticals share price?
The current share price of Rhythm Pharmaceuticals is US$ 56,54
How many Rhythm Pharmaceuticals shares are in issue?
Rhythm Pharmaceuticals has 61.457.069 shares in issue
What is the market cap of Rhythm Pharmaceuticals?
The market capitalisation of Rhythm Pharmaceuticals is USD 3,47B
What is the 1 year trading range for Rhythm Pharmaceuticals share price?
Rhythm Pharmaceuticals has traded in the range of US$ 35,17 to US$ 68,58 during the past year
What is the PE ratio of Rhythm Pharmaceuticals?
The price to earnings ratio of Rhythm Pharmaceuticals is -18,82
What is the cash to sales ratio of Rhythm Pharmaceuticals?
The cash to sales ratio of Rhythm Pharmaceuticals is 44,88
What is the reporting currency for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Rhythm Pharmaceuticals?
The latest annual turnover of Rhythm Pharmaceuticals is USD 77,43M
What is the latest annual profit for Rhythm Pharmaceuticals?
The latest annual profit of Rhythm Pharmaceuticals is USD -184,68M
What is the registered address of Rhythm Pharmaceuticals?
The registered address for Rhythm Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Rhythm Pharmaceuticals website address?
The website address for Rhythm Pharmaceuticals is www.rhythmtx.com
Which industry sector does Rhythm Pharmaceuticals operate in?
Rhythm Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
INTZIntrusion Inc
US$ 2,22
(393,33%)
44,69M
WIMIWiMi Hologram Cloud Inc
US$ 2,35
(82,17%)
15,09M
IDAIT Stamp Inc
US$ 0,9258
(71,44%)
19,92M
QSIQuantum Si Inc
US$ 3,35
(55,81%)
18,43M
SLDPSolid Power Inc
US$ 2,94
(50,77%)
13,26M
LATGChenghe Acquisition I Company
US$ 9,50
(-23,23%)
167
CUBLionheart Holdings
US$ 8,01
(-20,61%)
1
KALVKalVista Pharmaceuticals Inc
US$ 7,01
(-20,61%)
1
QRHCQuest Resource Holding Corporation
US$ 5,00
(-19,35%)
425
AIREreAlpha Tech Corporation
US$ 2,91
(-18,72%)
1,68M
INTZIntrusion Inc
US$ 2,22
(393,33%)
44,69M
IDAIT Stamp Inc
US$ 0,9258
(71,44%)
19,92M
QSIQuantum Si Inc
US$ 3,35
(55,81%)
18,43M
RVSNRail Vision Ltd
US$ 1,14
(47,36%)
17,09M
XTIAXTI Aerospace Inc
US$ 0,0432
(8,00%)
15,31M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
RYTM
Rhythm Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten